64B13-4.001: Examination Requirements
PURPOSE AND EFFECT: The purpose of this rule amendment is to specify the percentage ranges for the various items in the examination rather than exact percentages in the examination rule.
SUMMARY: The rule specifies the percentage rangers for examination items.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 456.017(2), 463.005, 463.006(2) FS.
LAW IMPLEMENTED: 456.017(2), 463.006(2) FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Joe Baker, Jr., Executive Director, Board of Optometry, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257
THE FULL TEXT OF THE PROPOSED RULE IS:
64B13-4.001 Examination Requirements.
The examination for licensure shall consist of the National Board of Examiners in Optometry examination (hereafter NBEO examination), and Parts I and II of the state examination for licensure. The examination for certification of a licensee shall consist of the Treatment and Management of Ocular Disease (hereafter TMOD) part of the NBEO.
(1) No change.
(2) State Examination.
(a) through (c) No change.
(d) Part II of the state examination shall consist of a clinical portion and a pharmacology/ocular disease portion.
1. The subject areas and associated weights for the clinical portion of the practical examination shall be as follows:
a. Confrontation Visual Field Testing for Neurologic Deficit (Finger Counting Visual Field Recognition, Location, and Disease Process) |
7-12% | |
b. Muscle Balance and Motility |
2-7% | |
c. Pupillary Examination |
8-13% 1-6% 1-6% 15-20% 17-22% 16-21% 9-14% 6-11% | |
d. Objective Examination (Retinoscopy) | ||
e. Subjective Refraction | ||
f. Internal Examination by Means of Binocular Indirect Ophthalmoscopy | ||
g. Biomicroscopy Anterior | ||
h. Biomicroscopy Posterior (Fundus Lens) | ||
i. Goldmann Tonometry | ||
j. Gonioscopy | ||
2. The grading criteria for each subject area and the points associated with each criterion shall be as follows:
a. Confrontation Visual Field Testing for Neurologic Deficit (Finger Counting and Visual Field Defect Recognition, Location, and Disease Process) |
6-11 | ||
1.1. Conducts specified visual field test in a manner consistent with obtaining accurate findings. Accurately identify visual field defect name, location, and disease process. | |||
b. Muscle Balance and Motility Testing |
3-8 | ||
1.1 Conducts examinations in a manner that will allow for evaluation of any phoric and or tropic posture, deficiencies in extra ocular muscles, or cranial nerve paresis. |
| ||
c. Pupillary Examination |
5-10 | ||
1.1 Conducts pupillary tests in a manner consistent with obtaining accurate findings. |
| ||
d. Objective Examination (Retinoscopy) |
2-7 | ||
1.1. Conducts Retinoscopy in a manner capable of obtaining a visual acuity of 20/30 |
| ||
e. Subjective Refraction |
2-7 | ||
1.1. Conducts refraction in a manner capable of obtaining a visual acuity of 20/20 |
| ||
f. Internal Examination by Means of Binocular Indirect Ophthalmoscopy |
16-21 | ||
1.1. Accurately views and evaluates retinal landmark as requested |
| ||
g. Biomicroscopy (Anterior) |
20-25 | ||
1.1. Uses proper technique to demonstrate requested views of anterior structures of eye |
| ||
h. Biomicroscopy Posterior (Fundus lens.) |
16-21 | ||
1.1. Accurately views and evaluates posterior landmarks as requested. |
| ||
i. Tonometry |
7-12 | ||
1.1. Demonstrates accurate technique for the measurement of intra-ocular pressure |
| ||
j. Gonioscopy |
4-9 | ||
1.1. Demonstrates accurate technique for identifying angle structures |
|
| |
3. through 6. No change.
(3) No change.
Rulemaking Specific Authority 456.017(2), 463.005, 463.006(2) FS. Law Implemented 456.017(2), 463.006(2) FS. History–New 11-13-79, Amended 5-28-80, 7-10-80, 8-20-81, 2-14-82, 6-6-82, 10-3-82, 4-10-84, 5-29-85, Formerly 21Q-4.01, Amended 7-21-86, 11-20-86, 7-27-87, 7-11-88, 7-18-91, 4-14-92, Formerly 21Q-4.001, Amended 2-14-94, Formerly 61F8-4.001, Amended 8-8-94, 11-21-94, 4-21-96, Formerly 59V-4.001, Amended 7-27-99, 7-15-02, 3-8-04,_________.